BetterLife Pharma Inc C.BETR

BetterLife Pharma (BETR) let’s go.....

[mrBlockchain]

Our new #1 favorite Psychstock for 2021 is Betterlife Pharma (CSE: BETR) or BETRF on the U.S. OTCQB. BETR is currently trading for $1.17 per share.

The psychedelic drug that Psychstocks Founder Gerard Adams believes has the biggest potential to effectively treat numerous mental health illnesses is LSD.

BETR has just acquired Transcend Biodynamics, which has its own patented process that allows for cost effective manufacturing of BOL-148, also known as 2-Bromo-LSD, without the need to make LSD. Transcend is the only entity with the ability to synthesize BOL-148 without the regulatory hurdles of handling a Schedule 1 controlled substance.

The patented process is known as "Process of synthesizing 2-bromo-LSD" and it was inventedby Justin Kirkland the CEO of BETR's newly acquired Transcend Biodynamics. BOL-148 is a nontoxic second-generation LSD-derived molecule that mimics the therapeutic potentialof LSD, without the hallucinations.

Gerard Adams is writing an in-depthPsychstocks report about BETR that he will publish next week. In addition, he will be profiling BETR in the final week of 2020 as his #1 psychedelic stock suggestion for 2021 to his NIA membership base.

[goldmike]

Stock closed up buying interest was strong on Friday after sell off. Should break $1.50 and head to old highs next year 

[BBAccount001]

Word is starting to get out about BOL-148. Once some trials are announced I see some very positive things happening for BETR's valuation... https://psilocybinalpha.com/news/psychedelic-bulletin-mindmed-raises-34-5m-tryp-goes-public-what-health-canadas-latest-amendment-means-for-psychedelics

[goldmike]

Stock was at $28 two years ago.. little downside with mega upside entree at $1.50 Break out point on 3 year chart should fly to $2.50 from here https://www.stockwatch.com/Chart/Advanced?time=1&symbol=BETR&region=C

[Nodga2000]

with this new addition BETR now has a fantastic portfolio of medicines. We could rocket even higher and today's move is just the start before a substantial rerate IMHO.

[goldmike]

BETR stock might hit $10 and here is why  just Look up Synairgen (SNG.L) gained by 456% in a single day on news of positive results from its clinical trial of SNG001, an inhaled formulation of interferon beta, in hospitalised COVID-19 patients. BETR has its own COVID-19 therapeutic called AP-003, an 

[goldmike]

Good example what can happen to BETR/BETRF stock  check competitor: $3,4B https://www.otcmarkets.com/stock/CYDY/news/CytoDyn-Completes-Enrollment-for-Phase-3-Registrational-Trial-for-390-Patients-with-Severe-to-Critical-COVID-19?id=283535